Lauren P. Bowers-Schewitz

Bristol, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia.

Systemic immunosuppression depletes peripheral blood regulatory B cells in patients with immune thrombocytopenia.

Journal: British journal of haematology

Published: December 19, 2022

Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2.

Epigenetic drug screen identified IOX1 as an inhibitor of Th17-mediated inflammation through targeting TET2.

Journal: EBioMedicine

Published: April 22, 2022

CD4+ T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expression.

CD4+ T cells from patients with glucocorticoid-refractory immune thrombocytopenia have altered cytokine expression.

Journal: British journal of haematology

Published: August 19, 2021

Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14++ CD16+ intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotype.

Glucocorticoid treatment in patients with newly diagnosed immune thrombocytopenia switches CD14++ CD16+ intermediate monocytes from a pro-inflammatory to an anti-inflammatory phenotype.

Journal: British journal of haematology

Published: July 14, 2020

IL-10 and IL-17 expression by CD4+ T cells is altered in corticosteroid refractory immune thrombocytopenia (ITP).

IL-10 and IL-17 expression by CD4+ T cells is altered in corticosteroid refractory immune thrombocytopenia (ITP).

Journal: Journal of thrombosis and haemostasis : JTH

Published: March 06, 2020

Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation.

Human Th17 cells produce a soluble mediator that increases podocyte motility via signaling pathways that mimic PAR-1 activation.

Journal: American journal of physiology. Renal physiology

Published: July 25, 2019

The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation.

The DNA Methylation Inhibitor Zebularine Controls CD4+ T Cell Mediated Intraocular Inflammation.

Journal: Frontiers in immunology

Published: May 09, 2019

Ex Vivo T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic Hepatitis.

Ex Vivo T Cell Cytokine Expression Predicts Survival in Patients with Severe Alcoholic Hepatitis.

Journal: Gut and liver

Published: January 27, 2019

The Bromodomain and Extra-Terminal Protein Inhibitor OTX015 Suppresses T Helper Cell Proliferation and Differentiation.

The Bromodomain and Extra-Terminal Protein Inhibitor OTX015 Suppresses T Helper Cell Proliferation and Differentiation.

Journal: Current molecular medicine

Published: August 22, 2018

Intermediate Monocytes in Acute Alcoholic Hepatitis Are Functionally Activated and Induce IL-17 Expression in CD4+ T Cells.

Intermediate Monocytes in Acute Alcoholic Hepatitis Are Functionally Activated and Induce IL-17 Expression in CD4+ T Cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: May 25, 2018

Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.

Glucocorticoid-resistant Th17 cells are selectively attenuated by cyclosporine A.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 17, 2015

Environmental conditioning in the control of macrophage thrombospondin-1 production.

Environmental conditioning in the control of macrophage thrombospondin-1 production.

Journal: Scientific reports

Published: October 17, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026